Patents Assigned to ULTRA-MICRORIGIN BIOMEDICAL TECHNOLOGY CO., LTD.
  • Patent number: 10214719
    Abstract: A method of culturing Antrodia cinnamomea with high Triterpenoids includes mixing a malt extract, glucose, peptone, agar, and a mushroom's extract with distilled water to obtain a culture medium; providing the culture medium to a high-pressure sterilization machine for sterilization to obtain a sterilized culture medium; providing the sterilized culture medium to an incubator in a disinfection environment to obtain a solidified culture medium after a predetermined time; transplanting Antrodia cinnamomeas strains to the solidified culture medium at separated positions; and exposing the solidified culture medium under a beam.
    Type: Grant
    Filed: August 14, 2017
    Date of Patent: February 26, 2019
    Assignee: Ultra-Microrigin Biomedical Technology Co., Ltd.
    Inventors: Ming-Hsi Chuang, Chu-Ting Liu, I-Lung Yu, Lin-Hsiang Chuang
  • Patent number: 9751956
    Abstract: A method of using supercritical fluid technology to separate and purify the functional components of Antrodia cinnamomea is described. Triterpenoids and polysaccharides of Antrodia cinnamomea are extracted from a fractionation tank containing extract of Antrodia cinnamomea and supercritical solvent at a set temperature and pressure. The extracted functional components and supercritical solvent are then continuously fed into three separating tanks at a set temperature and a pressure below that of the aforesaid pressure to obtain various functional components of triterpenoids and polysaccharides from the Antrodia cinnamomea feed in each separating tank.
    Type: Grant
    Filed: August 18, 2015
    Date of Patent: September 5, 2017
    Assignee: ULTRA-MICRORIGIN BIOMEDICAL TECHNOLOGY CO., LTD.
    Inventors: Ming-Hsi Chuang, Chu-Ting Lin, I-Lung Yu, Lin-Hsiang Chuang
  • Patent number: 9567365
    Abstract: The present invention provides a method of separating estrogen from placenta, which uses supercritical fluid technique to load the placenta powder of human body or sheep, pig, deer and other animals into an extraction tank. Under the operating conditions of preset pressure and temperature, supercritical solvent is added into the extraction tank to extract estrogen from placenta, so as to acquire de-estrogen placenta powder and placenta extract liquor. Under the same condition, the de-estrogen placenta extract liquor and supercritical solvent are added by a preset volume flow ratio into an adsorption tank. The estrogen in the placenta extract liquor is adsorbed by the adsorption tank to obtain de-estrogen placenta extract. It is then eluted with ethanol solution by gradient proportion to obtain purified natural estrogen.
    Type: Grant
    Filed: February 9, 2016
    Date of Patent: February 14, 2017
    Assignees: SUPER WELL BIOTECHNOLOGY CORPORATION, ULTRA-MICRORIGIN BIOMEDICAL TECHNOLOGY CO., LTD.
    Inventors: Zer-Ran Yu, Be-Jen Wang, Shu-Mei Lin, Hua-Ching Lin, Ming-Hsi Chuang, Chu-Ting Liu, Chiu-Ying Peng, Lin-Hsiang Chuang